As the clock ticks down on compliance deadlines, it is critical that compounding pharmacies and telehealth companies that prescribe GLP-1 medications review their practices, including pharmacy relationships, drug fulfillment, and patient-facing materials, to ensure they are prepared to adhere to the FDAs regulations for semaglutide and other compounded drugs
Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors
Endocrinology 149 , 574579 (2008)
My guess would be sometime in mid to late 2026 if they dont experience any hurdles in trial completion
The injection process Clean the injection site with an alcohol swab
Tirzepatide: A Side-by-Side Comparison Both semaglutide and tirzepatide are effective at aiding weight loss and improving specific metabolic markers